- Therapy of the Recurrent Basal Cell Carcinoma by Vismodegib2015 | Faculty of Medicine in Pilsen
- Vismodegib, a targeted therapy for advanced basalioma2013 | First Faculty of Medicine
- Erivedge ® (vismodegib) in advanced basocellular carcer therapy2013 | First Faculty of Medicine
- Research Report University Hospital of the clinical trial M025616Publication without faculty affiliation
- Lokálně pokročilý bazaliom léčený vismodegibem2017 | Third Faculty of Medicine
- A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegib2018 | Faculty of Medicine in Pilsen
- Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial2017 | Third Faculty of Medicine
- Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis2013 | Faculty of Medicine in Hradec Králové
- The primary cilia in oncology2015 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport
- Periocular basal cell carcinoma - clinical perspectives2020 | Central Library of Charles University
- Zkušenosti s léčbou nemocného s lokálně pokročilým bazaliomem preparátem Erivedge2017 | First Faculty of Medicine
- Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC2013 | Faculty of Medicine in Pilsen
- Alopecia and hair damage induced by oncological therapy2019 | Faculty of Medicine in Pilsen
- European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 20232023 | Third Faculty of Medicine
- The transcription factor GLI2 as a downstream mediator of transforming growth factor-beta-induced fibroblast activation in SSc2017 | First Faculty of Medicine
